Literature DB >> 14593744

The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.

W Jonathan Ryves1, Adrian J Harwood.   

Abstract

GSK-3 is a multifunctional protein kinase known to play a pivotal role in the regulation of metabolism, the cytoskeleton and gene expression. It also interacts with the cell cycle in a number of ways. GSK-3 forms part of both Wnt and Hh signalling pathways and hence controls expression of a number of cell cycle regulatory genes. Prominent among these is cyclin D1. GSK-3 also phosphorylates cyclin D1 to promote its nuclear export and subsequent degradation. In this chapter we examine how GSK-3 mediates these effects and consider how therapeutic strategies may be developed to specifically target these pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593744

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  14 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry.

Authors:  Amit Kumar; Miriam Marqués; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2006-10-02       Impact factor: 4.272

Review 3.  Phosphoinositide 3-kinase controls early and late events in mammalian cell division.

Authors:  Zaira García; Amit Kumar; Miriam Marqués; Isabel Cortés; Ana C Carrera
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

4.  Screening of cell cycle fusion proteins to identify kinase signaling networks.

Authors:  Michelle Trojanowsky; Dusica Vidovic; Scott Simanski; Clara Penas; Stephan Schurer; Nagi G Ayad
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation.

Authors:  Jie Liu; Sudha Agarwal
Journal:  J Immunol       Date:  2010-06-14       Impact factor: 5.422

6.  PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.

Authors:  Jin Ding; Beifang Ning; Yi Huang; Dongyun Zhang; Jingxia Li; Chang-Yan Chen; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

7.  Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.

Authors:  Miriam Marqués; Amit Kumar; Isabel Cortés; Ana Gonzalez-García; Carmen Hernández; M Carmen Moreno-Ortiz; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

Review 8.  GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.

Authors:  Michael K Rowe; Charlotte Wiest; De-Maw Chuang
Journal:  Neurosci Biobehav Rev       Date:  2007-03-15       Impact factor: 8.989

Review 9.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.

Authors:  Jia Luo
Journal:  Cancer Lett       Date:  2008-07-07       Impact factor: 8.679

10.  Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance.

Authors:  Katsuya Tanabe; Zhonghao Liu; Satish Patel; Bradley W Doble; Lin Li; Corentin Cras-Méneur; Sara C Martinez; Cris M Welling; Morris F White; Ernesto Bernal-Mizrachi; James R Woodgett; M Alan Permutt
Journal:  PLoS Biol       Date:  2008-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.